Citation Tools

Download PDFPDF

Initial experience of the safety and tolerability of the BNT162b2 (Pfizer-Bio-N-Tech) vaccine in extremely vulnerable children aged 12–15 years
Free

Download to a citation manager

Cite this article as:
King H, Deshpande S, Woodbridge T, et al
Initial experience of the safety and tolerability of the BNT162b2 (Pfizer-Bio-N-Tech) vaccine in extremely vulnerable children aged 12–15 years